SECTOR GAMMA AS - SANGAMO THERAPEUTICS INC ownership

SANGAMO THERAPEUTICS INC's ticker is SGMO and the CUSIP is 800677106. A total of 196 filers reported holding SANGAMO THERAPEUTICS INC in Q4 2019. The put-call ratio across all filers is 1.93 and the average weighting 0.0%.

Quarter-by-quarter ownership
SECTOR GAMMA AS ownership history of SANGAMO THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,772,000
-22.2%
211,698
-15.9%
0.28%
-26.2%
Q3 2019$2,278,000
-16.0%
251,6980.0%0.38%
-11.7%
Q2 2019$2,711,000
+19.0%
251,698
+5.4%
0.44%
+19.5%
Q1 2019$2,279,000
+28.1%
238,857
+54.1%
0.36%
+22.1%
Q4 2018$1,779,000
-32.3%
154,9600.0%0.30%
-27.4%
Q3 2018$2,627,000
+26.7%
154,960
+6.1%
0.41%
+19.4%
Q2 2018$2,073,000
+13.7%
146,000
+52.1%
0.34%
+4.9%
Q1 2018$1,824,00096,0000.33%
Other shareholders
SANGAMO THERAPEUTICS INC shareholders Q4 2019
NameSharesValueWeighting ↓
Golden State Equity Partners 154,360$897,0000.45%
Rhenman & Partners Asset Management AB 761,429$4,424,0000.44%
Lombard Odier Asset Management (Switzerland) SA 860,702$5,001,0000.39%
WASATCH ADVISORS LP 10,576,997$61,452,0000.30%
Rokos Capital Management LLP 977,663$5,861,0000.27%
KLK CAPITAL MANAGEMENT LLC 44,323$258,0000.26%
Long Focus Capital Management, LLC 340,000$1,975,0000.25%
Vanguard Capital Wealth Advisors 33,380$193,0000.14%
Fort Sheridan Advisors LLC 73,978$430,0000.13%
Delphia (USA) Inc. 20,983$122,0000.09%
View complete list of SANGAMO THERAPEUTICS INC shareholders